Volume 95 Issue 20 | p. 19 | Concentrates
Issue Date: May 15, 2017

Trade group sets new member criteria

Department: Business
Keywords: pharmaceuticals, R&D, drug pricing

The board of the trade association Pharmaceutical Research & Manufacturers of America has approved new criteria for membership that emphasizes R&D. The group also eliminated the “associate” category of membership. It now requires all members to have, on average over three years, an R&D-to-sales ratio of 10% or greater and R&D spending of at least $200 million per year. As a result, 22 companies—several of which have been criticized for their drug pricing practices—are no . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society